Free Trial

Nutex Health (NASDAQ:NUTX) Shares Up 8.2% - Here's Why

Nutex Health logo with Medical background

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) traded up 8.2% during trading on Monday . The stock traded as high as $123.04 and last traded at $124.05. 27,988 shares traded hands during mid-day trading, a decline of 53% from the average session volume of 60,026 shares. The stock had previously closed at $114.63.

Wall Street Analysts Forecast Growth

Separately, Maxim Group upped their price objective on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

View Our Latest Report on Nutex Health

Nutex Health Trading Up 14.6 %

The firm's 50 day moving average is $83.95 and its two-hundred day moving average is $53.70. The stock has a market cap of $726.10 million, a price-to-earnings ratio of -13.97 and a beta of 0.27. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Monday, March 31st. The company reported $11.12 EPS for the quarter, topping the consensus estimate of ($0.09) by $11.21. The firm had revenue of $81.30 million for the quarter, compared to analysts' expectations of $81.13 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

Insiders Place Their Bets

In other news, CFO Jon Christian Bates purchased 1,000 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the purchase, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 38.52% of the company's stock.

Institutional Trading of Nutex Health

Several institutional investors have recently made changes to their positions in the business. Bank of America Corp DE boosted its holdings in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after purchasing an additional 2,043 shares in the last quarter. Northern Trust Corp acquired a new stake in Nutex Health in the 4th quarter valued at $200,000. Baader Bank Aktiengesellschaft bought a new stake in Nutex Health in the fourth quarter valued at $206,000. Millennium Management LLC acquired a new position in Nutex Health during the fourth quarter worth $213,000. Finally, World Investment Advisors acquired a new position in shares of Nutex Health in the 4th quarter worth approximately $217,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines